The Hope Clinic of the Emory Vaccine Center, commonly known as Emory's Hope Clinic, is the clinical trials arm of the Emory Vaccine Center that is currently located near Dekalb Medical Center in Decatur, Georgia.

During the past decade, Emory Vaccine Center - The Hope Clinic conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 28 clinical trials were completed, i.e. on average, 45.2% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 23 clinical trials were completed. i.e. 63.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory Vaccine Center - The Hope Clinic" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 57 trials, followed by "Emory University" with 18 trials sponsored, "HIV Vaccine Trials Network" with 3 trials sponsored, "Janssen Vaccines & Prevention B.V." with 3 trials sponsored and "COVID-19 Prevention Network" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory Vaccine Center - The Hope Clinic" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials as a collaborator, "HIV Vaccine Trials Network" with 5 trials as a collaborator, "Centers for Disease Control and Prevention" with 3 trials as a collaborator, "HIV Prevention Trials Network" with 3 trials as a collaborator and "National Institutes of Health (NIH)" with 3 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Emory Vaccine Center - The Hope Clinic" are "HIV Infections" (20 trials), "COVID-19" (13 trials), "Influenza" (13 trials), "Avian Influenza" (3 trials) and "SARS-CoV-2" (3 trials). Many other conditions were trialed in "Emory Vaccine Center - The Hope Clinic" in a lesser frequency.

Most popular intervention types in "Emory Vaccine Center - The Hope Clinic" are "Biological" (64 trials), "Drug" (27 trials), "Other" (26 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Remdesivir" (6 trials), "mRNA-1273" (5 trials), "AS03" (4 trials) and "Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013" (3 trials). Other intervention names were less common.

The vast majority of trials in "Emory Vaccine Center - The Hope Clinic" are 82 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Emory Vaccine Center - The Hope Clinic". undefined are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 60 completed trials in Emory Vaccine Center - The Hope Clinic, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Emory Vaccine Center - The Hope Clinic, 34 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".